Is there a role for epidermal growth factor receptor inhibitors in breast cancer prevention?

Suppr

超能文献

作者信息

Konecny Gottfried E, Wilson Cindy A, Slamon Dennis J

出版信息

J Natl Cancer Inst. 2003 Dec 17;95(24):1813-5. doi: 10.1093/jnci/djg134.

DOI:10.1093/jnci/djg134

PMID:14679144

Abstract

摘要

相似文献

Is there a role for epidermal growth factor receptor inhibitors in breast cancer prevention?

J Natl Cancer Inst. 2003 Dec 17;95(24):1813-5. doi: 10.1093/jnci/djg134.

Effect of epidermal growth factor receptor inhibitor on development of estrogen receptor-negative mammary tumors.

J Natl Cancer Inst. 2003 Dec 17;95(24):1825-33. doi: 10.1093/jnci/djg117.

Getting to grips with gefitinib.

Lancet Oncol. 2003 Dec;4(12):719-20. doi: 10.1016/s1470-2045(05)70063-2.

EGFR inhibitors: clinical results.

Suppl Tumori. 2002 Nov-Dec;1(6):S5-6. doi: 10.1177/03008916020016s102.

Small-molecule epidermal growth factor receptor tyrosine kinase inhibitors.

Oncologist. 2003;8(6):576-86. doi: 10.1634/theoncologist.8-6-576.

Epidermal growth factor receptor tyrosine kinase inhibitors.

Curr Opin Pharmacol. 2002 Aug;2(4):382-7. doi: 10.1016/s1471-4892(02)00183-2.

Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor.

Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):12022-7. doi: 10.1073/pnas.95.20.12022.

BAD: a good therapeutic target?

Breast Cancer Res. 2003;5(1):27-30. doi: 10.1186/bcr552. Epub 2002 Oct 18.

Chemopreventive and therapeutic efficacy of orally active tyrosine kinase inhibitors in a transgenic mouse model of gallbladder carcinoma.

Clin Cancer Res. 2005 Aug 1;11(15):5572-80. doi: 10.1158/1078-0432.CCR-04-2603.

The ErbB receptor family: a therapeutic target for cancer.

Trends Mol Med. 2002;8(4 Suppl):S19-26. doi: 10.1016/s1471-4914(02)02306-7.

引用本文的文献

HER2 expression as a potential marker for response to therapy targeted to the EGFR.

Br J Cancer. 2006 Apr 24;94(8):1144-53. doi: 10.1038/sj.bjc.6603078.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Is there a role for epidermal growth factor receptor inhibitors in breast cancer prevention?

J Natl Cancer Inst. 2003 Dec 17;95(24):1813-5. doi: 10.1093/jnci/djg134.

Effect of epidermal growth factor receptor inhibitor on development of estrogen receptor-negative mammary tumors.

J Natl Cancer Inst. 2003 Dec 17;95(24):1825-33. doi: 10.1093/jnci/djg117.

Getting to grips with gefitinib.

Lancet Oncol. 2003 Dec;4(12):719-20. doi: 10.1016/s1470-2045(05)70063-2.

EGFR inhibitors: clinical results.

Suppl Tumori. 2002 Nov-Dec;1(6):S5-6. doi: 10.1177/03008916020016s102.

Small-molecule epidermal growth factor receptor tyrosine kinase inhibitors.

Oncologist. 2003;8(6):576-86. doi: 10.1634/theoncologist.8-6-576.

Epidermal growth factor receptor tyrosine kinase inhibitors.

Curr Opin Pharmacol. 2002 Aug;2(4):382-7. doi: 10.1016/s1471-4892(02)00183-2.

Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor.

Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):12022-7. doi: 10.1073/pnas.95.20.12022.

BAD: a good therapeutic target?

Breast Cancer Res. 2003;5(1):27-30. doi: 10.1186/bcr552. Epub 2002 Oct 18.

Chemopreventive and therapeutic efficacy of orally active tyrosine kinase inhibitors in a transgenic mouse model of gallbladder carcinoma.

Clin Cancer Res. 2005 Aug 1;11(15):5572-80. doi: 10.1158/1078-0432.CCR-04-2603.

The ErbB receptor family: a therapeutic target for cancer.

Trends Mol Med. 2002;8(4 Suppl):S19-26. doi: 10.1016/s1471-4914(02)02306-7.

引用本文的文献

HER2 expression as a potential marker for response to therapy targeted to the EGFR.

Br J Cancer. 2006 Apr 24;94(8):1144-53. doi: 10.1038/sj.bjc.6603078.